and there could always be a new partner for OPMD - there must have been many suitors when they were shopping it around before the Axovant deal. A few of them may resume discussions. That would restore our value quickly. Add to that new proprietary indications and we are back in the game.
BLT Price at posting:
7.3¢ Sentiment: Buy Disclosure: Held